Investing in the future
From early disease detection to better drug design and more efficient nanoelectronics 鈥� three 不良研究所 research projects share close to $11 million in awards from the CFI
The Canada Foundation for Innovation (CFI) has awarded an impressive $ 10,861,200 to three 不良研究所 researchers under its Leading Edge Fund (LEF). They will use the money to buy state-of-the-art equipment to work in fields ranging from nanomedicine to structural biology and nanoelectronics. One of the three projects involves collaborative research with Universit茅 de Montr茅al, which will share in the research funds. The funds from CFI will be matched by contributions made by the government of Quebec.
The three projects are:
Structural biology at the crossroads of biology and medicine - led by Prof. Kalle Gehring (Dept. of Biochemistry, Faculty of Medicine) 鈥� $ 4,834,800 鈥� a joint project with Universit茅 de Montr茅al.
The grant will give researchers an improved ability to visualize the three-dimensional shapes of biological molecules, such as proteins and nucleic acids. This should lead to a better understanding of the origins of diseases such as cancer and to the design of novel molecules for use in structure-based drug design and green chemistry.
Tools for nanoscience and technology upgrade 鈥� led by Prof. Peter Gr眉tter (Dept. of Physics, Faculty of Science) 鈥� $ 4,520,148.
Working at the nanolevel (a prefix used in standard measuring units to denote a factor of 10鈭�9 or one billionth), these funds will support cutting-edge research and development programs designed to improve energy efficiency in the fields of solar energy, information technology and biomedical applications of nanoscience and microtechnology.
Multiscale imaging and analysis of biological systems and biomaterials in nanomedicine 鈥� led by Prof. Marc McKee (Faculty of Dentistry) 鈥� $ 1,506,252
The researchers will use the grant to buy equipment that will allow them to take high-resolution images and analyze the biological processes that occur in proteins, cells and tissues at the subcellular, cellular and molecular level. The ultimate goal is to help researchers design targeted, site-specific therapeutics at the molecular scale, novel implant materials for tissue repair and regeneration, as well as new methods for the early diagnosis of disease.
The government of Canada created the CFI in 1997 to build Canada鈥檚 capacity to undertake world-class research and technology development to benefit Canadians. The LOF is designed to help researchers acquire the infrastructure needed to carry out innovative research.
鈥淩esearch and innovation is a forceful driver of growth in our communities,鈥� said Gilles G. Patry, president and CEO of the Canada Foundation for Innovation. 鈥淭oday鈥檚 funding will allow a talented group of researchers and students to create the solutions, products and ideas Canada needs to prosper.鈥�
鈥湶涣佳芯克� researchers apply their knowledge and imagination towards finding solutions to the problems that face us all,鈥� said Rose Goldstein, Vice-Principal (Research and International Relations) at 不良研究所. 鈥淲hether they are looking for ways to detect disease earlier on, developing more efficient nanoelectronics, or working to design better drugs, the support of the Canada Foundation for Innovation is essential to this research and we are very grateful for it.鈥�